Characterisation and expression of β1-, β2- and β3-adrenergic receptors in the fathead minnow (Pimephales promelas)

General and Comparative Endocrinology

Volumn 173, Issue 3, 2011, Pages 483-490

  Giltrow, Emma ^a   Eccles, Paul D ^a   Hutchinson, Thomas H ^b   Sumpter, John P ^a   Rand Weaver, Mariann ^a  

^a BRUNEL UNIVERSITY   (United Kingdom)

^b ASTRAZENECA   (United Kingdom)

Author keywords

Beta adrenergic receptor; Fathead minnow; G protein coupled receptor; Gene expression; Pimephales promelas; Propranolol exposure

Indexed keywords

AMINO ACID; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR; COMPLEMENTARY DNA; G PROTEIN COUPLED RECEPTOR; PROPRANOLOL;

AMINO ACID ANALYSIS; AMINO ACID SEQUENCE; AQUATIC ENVIRONMENT; ARTICLE; BRAIN; CHEMICAL STRUCTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA ISOLATION; DRUG EXPOSURE; DRUG RECEPTOR BINDING; ENVIRONMENTAL IMPACT; GENE EXPRESSION; HEART; LIGAND BINDING; LIVER; NONHUMAN; NUCLEOTIDE SEQUENCE; OVARY; PHYLOGENY; PIMEPHALES PROMELAS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN STRUCTURE; PROTEIN TARGETING; RISK ASSESSMENT; SEQUENCE ALIGNMENT;

EID: 80052480841     PISSN: 00166480     EISSN: 10956840     Source Type: Journal    
DOI: 10.1016/j.ygcen.2011.07.006     Document Type: Article

References (69)

1. Ampatzis K., Dermon C.R. Regional distribution and cellular localisation of β2-adrenoceptors in the adult zebrafish brain (Danio rerio). J. Comp. Neurol. 2010, 518:1418-1441.
2. Arakawa M., Yanamala N., Upadhyaya J., Halayko A., Klein-Seetharaman J., Chelikani P. The importance of valine 114 in ligand binding in β2-adrenergic receptor. Protein Sci. 2010, 19:85-93.
3. Aris-Brosou S., Chen X., Perry S.F., Moon T.W. Timing of the functional diversification of α- and β-adrenoceptors in fish and other vertebrates. Ann. NY Acad. Sci. 2009, 1163:343-347.
4. Ballesteros J.A., Weinstein H. Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein coupled receptors. Methods Neurosci. 1995, 25:366-428.
5. Berkowitz D.E., Nardone N.A., Smiley R.M., Price D.T., Kreutter D.K., Fremeau R.T., Schwinn D.A. Distribution of β3-adrenoceptor mRNA in human tissues. Eur. J. Pharmacol. 1995, 289:223-228.
6. Blom N., Sicheritz-Ponten T., Gupta R., Gammeltoft S., Brunal S. Prediction of post-translational glycosylation and phosphorylation of proteins from the amino acid sequence. Proteomics 2004, 4:1633-1649.
7. Brodde O.-E. β-adrenoceptor blocker treatment and the cardiac β-adrenoceptor-G-protein(s)-adenylyl cyclase system in chronic heart failure, Naunyn-Schmiedeberg's. Arch. Pharmacol. 2007, 374:361-372.
8. Caldwell D.J., Mastrocco F., Hutchinson T.H., Lange R., Heijerick D., Janssen C., Anderson P.D., Sumpter J.P. Derivation of an aquatic predicted no-effect concentration for the synthetic hormone 17α-ethinyl estradiol. Environ. Sci. Technol. 2008, 42:7046-7054.
9. Chen X., Harden T.K., Nicholas R.A. Molecular cloning and characterisation of a novel β-adrenergic receptor. J. Biol. Chem. 1994, 269:24810-24819.
10. Chen X., Perry S.F., Aris-Brosou S., Selva C., Moon T.W. Characterisation and functional divergence of the α1-adrenoceptor gene family: insights from rainbow trout (Oncorhynchus mykiss). Physiol. Genomics 2007, 32:142-153.
11. Cherezov V., Rosenbaum D.M., Hanson M.A., Rasmussen S.G.F., Foon S.T., Choi H.-J., Kuhn P., Weis W.I., Kobilka B.K., Stevens R.C. High-resolution crystal structure of an engineered human β2-adrenergic G protein-coupled receptor. Science 2007, 318:1258-1265.
12. Cikos S., Vesela J., Il'kova G., Rehak P., Czikkova S., Koppel J. Expression of beta adrenergic receptors in mouse oocytes and preimplantation embryos. Mol. Reprod. Dev. 2005, 71:145-153.
13. Civantos Calzada B., Aleixandre De Artinano A. Alpha-adrenoceptor subtypes. Pharmacol. Res. 2001, 44:195-208.
14. Cleuvers M. Initial risk assessment for three beta-blockers found in the aquatic environment. Chemosphere 2005, 59:199-205.
15. Dugan S.G., Lortie M.B., Nickerson J.G., Moon T.W. Regulation of the rainbow trout (Oncorhynchus mykiss) hepatic β-adrenoceptor by adrenergic agonists. Comp. Biochem. Physiol. 2003, 136B:331-342.
16. Dugan S.G., Chen X., Nickerson J.G., Montpetit C.J., Moon T.W. Regulation of the black bullhead hepatic β-adrenoceptors. Comp. Biochem. Physiol. 2008, 149B:265-274.
17. Emorine L.J., Marullo S., Briend-Surtren M.M., Patey G., Tate K., Delavier-Klutchko C., Strosberg A.D. Molecular characterization of the human β3-adrenergic receptor. Science 1989, 245:1118-1121.
18. Ericson H., Thorsen G., Kumblad L. Physiological effects of diclofenac, ibuprofen and propranolol on Baltic Sea blue mussels. Aquat. Toxicol. 2010, 99:223-231.
19. Fabbri E., Capuzzo A., Moon T.W. The role of circulating catecholamines in the regulation of fish metabolism: an overview. Comp. Biochem. Physiol. 1998, 120C:177-192.
20. Freddolino P.L., Kalani M.Y.S., Vaidehi N., Floriano W.B., Hall S.E., Trabanino R.J., Kam V.W.T., Goddard W.A. Predicted 3D structure for the human β2 adrenergic receptor and its binding site for agonists and antagonists. Proc. Natl. Acad. Sci. 2004, 101:2736-2741.
21. Froschauer A., Braasch I., Volff J.N. Fish genomes, comparative genomics and vertebrate evolution. Curr. Genomics 2006, 7:43-57.
22. Gamperl A.K., Vijayan M.M., Pereira C., Farrell A.P. β-Receptors and stress protein 70 expression in hypoxic myocardium of rainbow trout and chinook salmon. Am. J. Physiol. 1998, 274:R428-R436.
23. Gether U. Uncovering molecular mechanisms involved in activation of G protein-coupled receptors. Endocr. Rev. 2000, 21:90-113.
24. Gibbs M.E., Hutchinson D.S., Summers R.J. Noradrenaline release in the locus coeruleus modulates memory formation and consolidation; roles for α- and β-adrenergic receptors. Neuroscience 2010, 170:1209-1222.
25. Giltrow E., Eccles P.D., Winter M.J., McCormack P.J., Rand-Weaver M., Hutchinson T.H., Sumpter J.P. Chronic effects assessment and plasma concentrations of the β-blocker propranolol in fathead minnows (Pimephales promelas). Aquat. Toxicol. 2009, 95:195-202.
26. Hall R.A. β-Adrenegic receptors and their interacting proteins. Sem. Cell Dev. Biol. 2004, 15:281-288.
27. Hertz L., Lovatt D., Goldman S.A., Nedergaard M. Adrenoceptors in brain: cellular gene expression and effects on astrocytic metabolism and [Ca2+]I. Neurochem. Intl. 2010, 57:411-420.
28. Horinouchi T., Morishima S., Tanaka T., Suzuki F., Tanaka Y., Koike K., Miwa S., Muramatsu I. Different changes of plasma membrane β-adrenoceptors in rat heart after chronic administration of propranolol, atenolol and bevantolol. Life Sci. 2007, 81:399-404.
29. Imbrogno S., Angelone T., Adamo C., Pulera E., Tota B., Cerra M.C. Beta3-adrenoceptor in the eel (Anguilla anguilla) heart: negative inotropy and NO-cGMP-dependent mechanism. J. Exp. Biol. 2006, 209:4966-4973.
30. Jones O.A.H., Voulvoulis N., Lester J.N. Potential ecological and human health risks associated with the presence of pharmaceutically active compounds in the aquatic environment. Crit. Rev.Toxicol. 2004, 34:335-350.
31. Kawasaki T., Saito K., Deguchi T., Fujimori K., Tadokoro M., Yuba S., Ohgushi H., Kawarabayasi Y. Pharmacological characterisation of isoproterenol-treated medaka fish. Pharmacol. Res. 2008, 58:348-355.
32. Kelly E., Bailey C.P., Henderson G. Agonist-selective mechanisms of GPCR desensitisation. Br. J. Pharmacol. 2008, 153:S379-S388.
33. Knacker T., Duis K., Ternes T., Fenner K., Escher B., Schmitt H., Rombke J., Garric J., Hutchinson T.H., Boxall A.B. The EU-project ERAPharm, incentives for the further development of guidance documents?. Environ. Sci. Pollut. Res. Int. 2005, 12:62-65.
34. Krief S., Lonnqvist F., Raimbault S., Baude B., van Spronsen A., Arner P., Strosberg D.A., Ricquier D., Emorine L.J. Tissue distribution of β3-adrenergic receptor mRNA in man. J. Clin. Invest. 1993, 91:344-349.
35. Krystek S.R., Kimura S.R., Tebben A.J. Modeling and active site refinement for G-protein-coupled receptors: application to the β-2 adrenergic receptor. J. Comput. Aided Mol. Des. 2006, 20:463-470.
36. Larkin M.A., Blackshields G., Brown N.P., Chenna R., McGettigan P.A., McWilliam H., Valentin F., Wallace I.M., Wilm A., Lopez R., Thompson J.D., Gibson T.J., Higgins D.G. Clustal W and Clustal X version 2.0. Bioinformatics 2007, 23:2947-2948.
37. Michel M.C., Harding S.E., Bond R.A. Are there functional β3-adrenoceptors in the human heart?. Br. J. Pharmacol. 2011, 162:817-822.
38. Millar R.P., Newton C.L. The year in G protein-coupled receptor research. Mol. Endocrinol. 2010, 24:261-274.
39. Milting H., Scholz C., Arusoglu L., Freitag M., Cebulla R., Jaquet K., Korfer R., Lewinski D., Kassner A., Brodde O.E., Kogler H., El-Banayosy A., Pieske B. Selective upregulation of β1-adrenergic receptors and dephosphorylation of troponin 1 in end-stage heart failure patients supported by ventricular assist devices. J. Mol. Cell. Cardiol. 2006, 41:441-450.
40. M.A. Moen, S.F. Owen, T.H. Hutchinson, M.J. Hetheridge, L.A. Constantine, J.P. Sumpter, D.B. Huggett, Pharmaceutical plasma concentrations in fish as a prediction tool for toxicity: case studies with 17α-ethinylestradiol and propranolol, SETAC North America 28th Annual Meeting (2007).
41. Nickerson J.G., Dugan S.G., Drouin G., Moon T.W. A putative β2-adrenoceptor from the rainbow trout (Oncorhynchus mykiss). Eur. J. Biochem. 2001, 268:6465-6472.
42. Nickerson J.G., Dugan S.G., Drouin G., Perry S.F., Moon T.W. Activity of the unique β-adrenergic Na+/H+ exchanger in trout erythrocytes is controlled by a novel β3-AR subtype. Am. J. Physiol. Regul. Integr. Comp. Physio. 2003, 285:R526-R535.
43. Owen S.F., Huggett D.B., Hutchinson T.H., Hetheridge M.J., Kinter L.J., Ericson J.F., Sumpter J.P. Uptake of propranolol, a cardiovascular pharmaceutical, from water into fish plasma and its effects on growth and organ biometry. Aquat. Toxicol. 2009, 93:217-224.
44. Palczewski K., Kumasaka T., Hori T., Behnke C.A., Motoshima H., Fox B.A., Le Trong I., Teller D.C., Okada T., Stenkamp R.E., Yamamoto M., Miyano M. Crystal structure of rhodopsin: a G protein-coupled receptor. Science 2000, 289:739-745.
45. Pierce K.L., Lefkowitz R.J. Classical and new roles of β-arrestins in the regulation of G-protein-coupled receptors. Nature Rev. 2008, 2:727-733.
46. Rasmussen S.G.F., Choi H.-J., Rosenbaum D.M., Kobilka T.S., Thian F.S., Edwards P.C., Burghammer M., Ratnala V.R.P., Sanishvili R., Fischetti R.F., Schertler G.F.X., Weis W.I., Kobilka B.K. Crystal structure of the human β2 adrenergic G-protein-coupled receptor. Nature 2007, 450:383-388.
47. Ren J., Wen L., Gao X., Jin C., Xue Y., Yao X. CSS-Palm 2.0: an updated software for palmitoylation sites prediction. Protein Eng. Des. Sel. 2008, 21:639-644.
48. Rizza R.A., Cryer P.E., Haymond M.W., Gerich J.E. Adrenergic mechanisms for the effects of epinephrine on glucose production and clearance in man. J. Clin. Invest. 1980, 65:682-689.
49. Rockman H.A., Koch W.J., Lefkowitz R.J. Seven-transmembrane-spanning receptors and heart function. Nature 2002, 415:206-212.
50. Rodriguez M., Carillon C., Coquerel A., Le Fur G., Ferrara P., Caput D., Shire D. Evidence for the presence of β3-adrenergic receptor mRNA in the human brain. Mol. Brain Res. 1995, 29:369-375.
51. Rouget C., Bardou M., Breuiller-Fouche M., Loustalot C., Qi H., Naline E., Croci T., Cabrol D., Advenier C., Leroy M.J. β3-Adrenoceptor is the predominant β-adrenoceptor subtype in human myometrium and its expression is upregulated in pregnancy. J. Clin. Endocrinol. Metab. 2005, 90:1644-1650.
52. Rosenbaum D.M., Rasmussen S.G.F., Koblika B.K. The structure and function of G-protein-coupled receptors. Nature 2009, 459:356-363.
53. Runnalls T.J., Margiotta-Casaluci L., Kugathas S., Sumpter J.P. Pharmaceuticals in the aquatic environment: steroids and anti-steroids as high priorities for research. Hum. Ecol. Risk Assess. 2010, 16:1318-1338.
54. Ruuskanen J.O., Laurila J., Xhaard H., Rantanen V., Vuoriluoto K., Wurster S., Marjamäki A., Vainio M., Johnson M.S., Scheinin M. Conserved structural, pharmacological and functional properties among the three human and five zebrafish α2-adrenoceptors. Br. J. Pharmacol. 2005, 144:165-177.
55. Santos L.H., Araújo A.N., Fachini A., Pena A., Delerue-Matos C., Montenegro M.C. Ecotoxicological aspects related to the presence of pharmaceuticals in the aquatic environment. J. Hazard. Mater. 2010, 175:45010.
56. Schwerte T., Prem C., Mairosl A., Pelster B. Development of the sympatho-vagal balance in the cardiovascular system in zebrafish (Danio rerio) characterised by power spectrum and classical signal analysis. J. Exp. Biol. 2006, 209:1093-1100.
57. Shi L., Liapakis G., Xu R., Guarnieri F., Ballesteros J.A., Javitch J.A. β2 Adrenergic receptor activation: modulation of the proline kink in transmembrane 6 by a rotamer toggle switch. J. Biol. Chem. 2002, 277:40969-40989.
58. Sterin-Boda L., Bernabeo G., Ganzinelli S., Joensen L., Borda E. Role of nitric oxide/cyclic GMP and cyclic AMP in β3 adrenoceptor-chronotropic response. J. Mol. Cell. Cardiol. 2006, 40:580-588.
59. Strosberg A.D. Structural and functional diversity of β-adrenergic receptors. Ann. NY Acad. Sci. 1995, 757:253-260.
60. Strosberg A.D., Pietri-Rouxel F. Function and regulation of the β3-adrenoceptor. Trends Pharmacol. Sci. 1996, 17:373-381.
61. Sumpter J.P. Environmental effects of human pharmaceuticals. Drug Info. J. 2007, 41:143-147.
62. Ternes T.A. Occurrence of drugs in German sewage treatment plants and rivers. Water Res. 1998, 32:3245-3260.
63. Towbin A.B., Butcher A.J., Kong K.C. Location, location, location...site-specific GPCR phosphorylation offers a mechanism for cell-type-specific signalling. Trends Pharmacol. Sci. 2008, 29:413-420.
64. Van Heeswijk J.C.F., Vianen G.J., van den Thillart G.E.E.J.M. The adrenergic control of hepatic glucose and FFA metabolism in rainbow trout (Oncorhynchus mykiss): increased sensitivity to adrenergic stimulation with fasting. Gen. Comp. Endocrinol. 2006, 145:51-61.
65. Vieno N.M., Tuhkanen T., Kronberg L. Analysis of neutral and basic pharmaceuticals in sewage treatment plants and in recipient rivers using solid phase extraction and liquid chromatography-tandem mass spectrometry detection. J. Chromatogr. A 2006, 1134:101-111.
66. Volff J.N. Genome evolution and biodiversity in teleost fish. Heredity 2005, 94:280-294.
67. Wang Z., Nishimura Y., Shimada Y., Umemoto N., Hirano M., Zang L., Oka T., Sakamoto C., Kuroyanagi J., Tanaka T. Zebrafish β-adrenergic receptor mRNA expression and control of pigmentation. Gene 2009, 446:18-27.
68. Warne T., Serrano-Vega M.J., Baker J.G., Moukhametzianov R., Edwards P.C., Henderson R., Leslie A.G.W., Tate C.G., Schertler G.F.X. Structure of a β1-adrenergic G-protein-coupled receptor. Nature 2008, 454:486-492.
69. Winter M.J., Lillicrap A.D., Caunter J.E., Schaffner C., Alder A.C., Ramnil M., Ternes T.A., Giltrow E., Sumpter J.P., Hutchinson T.H. Defining the chronic impacts of atenolol on embryo-larval development and reproduction in the fathead minnow. Aquat. Toxicol. 2008, 86:361-369.